Triphala Churna in classical Ayurveda

What it is

Triphala is Sanskrit for three (tri) plus fruits (phala), and the name is the whole formula: the dried fruits of three species, mixed in equal proportions (Peterson et al., 2017):

| Fruit | Sanskrit name | Latin binomial | Part used | |---|---|---|---| | Indian gooseberry | Amalaki | Emblica officinalis Gaertn. | dried fruit | | Beleric myrobalan | Bibhitaki | Terminalia bellirica (Gaertn.) Roxb. | dried fruit | | Chebulic myrobalan | Haritaki | Terminalia chebula Retz. | dried fruit |

The fruits are dried, powdered, and blended. That powder is triphala churna, because churna just means powder. Laboratory analyses have identified a rich tannin and polyphenol profile in the blend, including chebulagic acid, chebulinic acid, gallic acid, and ellagic acid (IJPPP review, 2025). Polyphenol-rich is interesting. It is not the same as proven effective. We keep that distinction in mind whenever we read about this formula.

Classical properties

• Taste (rasa): astringent (Kashaya), sour (Amla), pungent (Katu), bitter (Tikta), sweet (Madhura)
• Qualities (guna): light (Laghu), dry (Ruksha)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): sweet (Madhura)
• Doshas: traditionally described as balancing for all three

Traditional use

In Ayurvedic medical literature, triphala is described as a cornerstone of gastrointestinal and rejuvenative (rasayana) treatment (Peterson et al., 2017). Classical practice uses it for vibandha (constipation) as a mild, non-violent laxative, and as a general digestive tonic.

Those are traditional indications. Long clinical history, and we mean genuinely long. But history is not clinical proof, and the next section is where we check whether proof exists.

What research has looked at

Constipation and bowel regularity

This is the best-studied human use, so we will spend the most time here. In a randomized controlled trial, adults with constipation received either triphala churna or a prescribed dietary module. Both groups showed statistically significant laxative effects on the assessed parameters. One honest wrinkle: the diet arm performed better on weekly bowel-movement frequency and colic pain (RCT indexed in DOAJ). Triphala worked. Diet worked a bit better on two measures. We are reporting both because that is what the trial found.

Separately, an open-label prospective trial (n=34) of an Ayurvedic proprietary formula containing triphala extract plus isabgol husk and senna reported increased weekly bowel movements and improved Bristol stool-form scores over 14 days (J-AIM, 2011). Three caveats, and we insist on all three. That study tested a combination product, not triphala alone. It was open-label with a small sample. And three of its authors were affiliated with Tulip Lab Private Limited, the manufacturer of the tested formulation. None of that makes the result false. It makes it weaker than it looks at first glance.

Antioxidant, anti-inflammatory and other pharmacological effects

A 2017 peer-reviewed review of the triphala literature catalogues a long list of reported properties: antioxidant, anti-inflammatory, immunomodulating, antibacterial, and others. But the review is explicit that nearly all of this evidence comes from laboratory and animal studies, and it flags the need for human clinical investigation (Peterson et al., 2017).

A 2025 review catalogues broad pharmacological effects as well, calls for advanced clinical research, and takes a more optimistic view of triphala's therapeutic potential (IJPPP review, 2025). Optimism in a review is not data. We note the difference in tone between the two reviews and move on, because neither review adds a human trial.

Gut microbiome

The 2017 review discusses early experimental reports and hypothesizes that triphala polyphenols shift gut microbial populations (promoting Bifidobacteria and Lactobacillus while suppressing less desirable microbes), with the bioactivity partly mediated by gut bacteria generating anti-inflammatory compounds (Peterson et al., 2017). This is preclinical work. No human trial has confirmed a microbiome-mediated clinical benefit. An interesting hypothesis is still a hypothesis.

What the evidence does not yet show

Human evidence for triphala beyond constipation is limited but not zero. A 12-week double-blind randomized placebo-controlled trial (n=62) found triphala-treated subjects lost about 5 kg versus placebo (Kamali et al., 2012). A 2025 meta-analysis of 15 controlled trials found a smaller average weight difference (−2.4 kg) with high heterogeneity and variable study quality (Salehi et al., 2025). These are small, preliminary signals. Not proof of a weight-loss effect. The gap between those numbers and what marketing claims is wide, and we want you to see it.

For "detoxification": that is not a measurable clinical endpoint, and no trial has tested it. For cancer treatment or prevention, there are no human trials; the reviews list antineoplastic effects strictly among preclinical findings requiring clinical development (Peterson et al., 2017). Treat such claims as unproven. We do.

Safety notes

• In the 14-day J-AIM open-label trial (n=34), the triphala-containing formula was well tolerated: no adverse events were reported and safety laboratory parameters showed no significant changes. But this was a short trial of a combination product, not triphala churna alone (J-AIM, 2011).
• Dedicated long-term safety trials of triphala churna alone are lacking. That gap is real and we will not fill it with reassurance.
• As with any laxative, prolonged daily use without medical guidance is inadvisable.

FAQs

Does triphala churna help with constipation?

Yes, with the usual qualifications. A randomized trial found that triphala churna produced significant laxative effects in constipated adults, though a prescribed dietary module performed slightly better on two measures (RCT indexed in DOAJ). An open-label study of a triphala-containing formula also reported improved bowel frequency and stool form (J-AIM, 2011). This is the strongest human evidence on this page. It is still one RCT.

Is triphala safe to take every day?

Short-term trial use was well tolerated, but long-term daily-use safety has not been studied in humans. That is the whole answer, and it is not reassuring enough to act on alone. Because it acts as a laxative, ongoing daily use should involve a qualified practitioner rather than self-direction.

Can triphala help with weight loss?

Limited human evidence exists. One 12-week randomized placebo-controlled trial (n=62) reported about 5 kg more weight loss with triphala than placebo (Kamali et al., 2012), and a 2025 meta-analysis of 15 controlled trials found a smaller average effect (−2.4 kg) with high variability (Salehi et al., 2025). This is a preliminary signal, not proof. Marketing claims go well beyond what the trials show, and we would keep our wallet closed until the trials catch up.

When is the best time to take triphala churna?

The constipation trial administered it at night after the evening meal with lukewarm water (RCT indexed in DOAJ). That is the trial's timing, not a traditional rule we are inventing.

What are the three fruits in triphala?

Amalaki (Emblica officinalis), bibhitaki (Terminalia bellirica) and haritaki (Terminalia chebula). Equal parts dried fruit, powdered (Peterson et al., 2017). Three fruits, equal proportions, dried and ground. That is the entire formula.

Does triphala "detox" the body?

"Detox" is not a measurable clinical endpoint, and no trial has tested it. Triphala does show antioxidant activity in lab studies, but that is not the same as detoxifying the body (Peterson et al., 2017). When someone sells you detox, ask what they are measuring. They will not have an answer.

Sources

Peterson, Denniston, and Chopra's 2017 review, "Therapeutic Uses of Triphala in Ayurvedic Medicine" (Journal of Alternative and Complementary Medicine 23(8):607–614), is the backbone of this article: the three-fruit composition, the traditional indications, the catalogue of preclinical findings, and the microbiome hypothesis all run through it (full text). The 12-week weight trial is Kamali et al.'s 2012 randomized, double-blind, placebo-controlled trial of Itrifal Saghir (triphala), n=62 (PMC3559014).

The combination-product constipation trial is Mukherjee et al.'s 2011 open-label prospective study in the Journal of Ayurveda and Integrative Medicine (PMC3193686, PubMed: PubMed · PMID 22022157). The triphala-alone constipation RCT is indexed in DOAJ (record). The broader pharmacological picture comes from Bairwa's 2025 review in the International Journal of Physiology, Pathophysiology and Pharmacology (PDF), and the weight-loss pooled estimate from Salehi et al.'s 2025 systematic review and meta-analysis in the Journal of Medicinal Natural Products (doi:10.53941/jmnp.2025.100021).

Disclaimer

This article is for educational purposes only and is not medical advice. Triphala churna is a traditional Ayurvedic formulation; the human clinical evidence for it is limited, with short human trials mainly on constipation. Consult a qualified Ayurvedic practitioner or physician before use, especially if you are pregnant, nursing, taking medication, or managing a medical condition.